HIF1A and neoplasm: Specifically, the metabolism advantage organoid HCC272 could remodel tumor microenvironment through accelerating the usage of glucose, enhancing hypoxia‐induced HIF‐1 signaling, and leading to the upregulation of NEAT1 in CD44high cells, which induce the hyper‐activation of Jak‐STAT signaling eventually caused drug resistance.